vs
Side-by-side financial comparison of Atara Biotherapeutics, Inc. (ATRA) and Expion360 Inc. (XPON). Click either name above to swap in a different company.
Expion360 Inc. is the larger business by last-quarter revenue ($2.2M vs $1.6M, roughly 1.4× Atara Biotherapeutics, Inc.). On growth, Expion360 Inc. posted the faster year-over-year revenue change (11.8% vs -95.1%). Over the past eight quarters, Expion360 Inc.'s revenue compounded faster (51.1% CAGR vs -75.9%).
Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic T-cell immunotherapies for patients with unmet medical needs across oncology, autoimmune disease, and infectious disease indications. It operates primarily in North America, Europe, and Asia-Pacific, partnering with research institutions to advance its novel treatment pipeline.
Expion360 Inc. is a provider of high-performance lithium iron phosphate (LFP) battery solutions and supporting energy storage products. Its core customer segments cover recreational vehicle owners, marine users, off-grid lifestyle enthusiasts and residential users across the U.S. market, delivering safe, durable and low-carbon energy storage options.
ATRA vs XPON — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $2.2M |
| Net Profit | — | $-4.4M |
| Gross Margin | — | -14.8% |
| Operating Margin | — | -234.4% |
| Net Margin | — | -199.9% |
| Revenue YoY | -95.1% | 11.8% |
| Net Profit YoY | 73.2% | -1663.2% |
| EPS (diluted) | — | $-0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $2.2M | ||
| Q3 25 | $3.5M | $2.4M | ||
| Q2 25 | $17.6M | $3.0M | ||
| Q1 25 | $98.1M | $2.0M | ||
| Q4 24 | $32.8M | $2.0M | ||
| Q3 24 | $40.2M | $1.4M | ||
| Q2 24 | $28.6M | $1.3M | ||
| Q1 24 | $27.4M | $971.9K |
| Q4 25 | — | $-4.4M | ||
| Q3 25 | $-4.3M | $722.8K | ||
| Q2 25 | $2.4M | $-1.4M | ||
| Q1 25 | $38.0M | $-1.2M | ||
| Q4 24 | $-12.7M | $-251.6K | ||
| Q3 24 | $-21.9M | $-8.8M | ||
| Q2 24 | $-19.0M | $-2.2M | ||
| Q1 24 | $-31.8M | $-2.2M |
| Q4 25 | — | -14.8% | ||
| Q3 25 | — | 22.7% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 24.5% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 25.5% | ||
| Q1 24 | — | 22.9% |
| Q4 25 | — | -234.4% | ||
| Q3 25 | -103.5% | -125.4% | ||
| Q2 25 | 18.2% | -45.2% | ||
| Q1 25 | 39.5% | -56.0% | ||
| Q4 24 | -37.3% | -59.5% | ||
| Q3 24 | -54.1% | -138.7% | ||
| Q2 24 | -63.7% | -131.4% | ||
| Q1 24 | -114.2% | -202.4% |
| Q4 25 | — | -199.9% | ||
| Q3 25 | -124.6% | 30.2% | ||
| Q2 25 | 13.6% | -45.8% | ||
| Q1 25 | 38.7% | -56.2% | ||
| Q4 24 | -38.8% | -12.7% | ||
| Q3 24 | -54.5% | -634.4% | ||
| Q2 24 | -66.5% | -173.7% | ||
| Q1 24 | -116.1% | -225.6% |
| Q4 25 | — | $-0.45 | ||
| Q3 25 | $-0.32 | $0.10 | ||
| Q2 25 | $0.19 | $-0.41 | ||
| Q1 25 | $3.50 | $-0.37 | ||
| Q4 24 | $0.27 | $65.02 | ||
| Q3 24 | $-2.93 | $-24.55 | ||
| Q2 24 | $-3.10 | $-30.20 | ||
| Q1 24 | $-5.65 | $-31.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | $3.0M |
| Total DebtLower is stronger | — | $197.2K |
| Stockholders' EquityBook value | $-38.5M | $6.5M |
| Total Assets | $20.2M | $8.1M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | $3.0M | ||
| Q3 25 | $13.7M | $4.3M | ||
| Q2 25 | $22.3M | $684.9K | ||
| Q1 25 | $13.8M | $1.1M | ||
| Q4 24 | $42.5M | $547.6K | ||
| Q3 24 | $67.2M | $3.3M | ||
| Q2 24 | $35.3M | $902.3K | ||
| Q1 24 | $46.2M | $2.3M |
| Q4 25 | — | $197.2K | ||
| Q3 25 | — | $205.6K | ||
| Q2 25 | — | $213.6K | ||
| Q1 25 | — | $221.8K | ||
| Q4 24 | — | $230.2K | ||
| Q3 24 | — | $239.9K | ||
| Q2 24 | — | $247.7K | ||
| Q1 24 | — | $255.4K |
| Q4 25 | $-38.5M | $6.5M | ||
| Q3 25 | $-36.6M | $9.0M | ||
| Q2 25 | $-35.0M | $2.1M | ||
| Q1 25 | $-55.1M | $3.2M | ||
| Q4 24 | $-97.3M | $2.5M | ||
| Q3 24 | $-90.5M | $2.5M | ||
| Q2 24 | $-110.9M | $2.5M | ||
| Q1 24 | $-98.3M | $3.7M |
| Q4 25 | $20.2M | $8.1M | ||
| Q3 25 | $30.2M | $10.7M | ||
| Q2 25 | $36.9M | $8.6M | ||
| Q1 25 | $62.0M | $9.2M | ||
| Q4 24 | $109.1M | $9.1M | ||
| Q3 24 | $142.7M | $10.1M | ||
| Q2 24 | $117.3M | $8.8M | ||
| Q1 24 | $165.3M | $10.0M |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-50.9M | $-2.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-50.9M | $-2.4M | ||
| Q3 25 | $-9.8M | $-2.1M | ||
| Q2 25 | $-7.3M | $-401.0K | ||
| Q1 25 | $-28.1M | $-1.2M | ||
| Q4 24 | $-24.5M | $-2.9M | ||
| Q3 24 | $-4.0M | $-3.2M | ||
| Q2 24 | $-10.6M | $-1.7M | ||
| Q1 24 | $-29.6M | $-1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-24.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-10.7M | — | ||
| Q1 24 | $-29.7M | $-1.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -75.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -37.3% | — | ||
| Q1 24 | -108.7% | -173.1% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.5% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.90× | ||
| Q2 25 | -3.07× | — | ||
| Q1 25 | -0.74× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
